<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33380/2305-2066-2022-11-3-209-219</article-id><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-1303</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ И КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRECLINICAL AND CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Исследование эффективности действия препаратов на основе молекулярных комплексов аденозин-полимер на модели термического ожога</article-title><trans-title-group xml:lang="en"><trans-title>Study of the Effectiveness of Drugs Based on Molecular Complexes of Adenosine-polymer on the Model of Thermal Burn</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8464-7711</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семивеличенко</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Semivelichenko</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, г. Санкт-Петербург, ул. Профессора Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><email xlink:type="simple">evgeniy.semivelichenko@pharminnotech.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6040-2795</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ермолаева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ermolaeva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, г. Санкт-Петербург, ул. Профессора Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8077-3358</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пономаренко</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponomarenko</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, г. Санкт-Петербург, ул. Профессора Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3042-2269</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новоселов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Novoselov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>199004, г. Санкт-Петербург, В. О. Большой пр., д. 31</p></bio><bio xml:lang="en"><p>31, Bolshoy pr., Saint-Petersburg, 199004</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0869-3430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плиско</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Plisko</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, г. Санкт-Петербург, ул. Профессора Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9273-6864</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ивкин</surname><given-names>Д. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivkin</surname><given-names>D. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, г. Санкт-Петербург, ул. Профессора Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9910-5395</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антонов</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Antonov</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>194044, г. Санкт-Петербург, ул. Академика Лебедева, д. 6, лит. Ж</p></bio><bio xml:lang="en"><p>6Zh, Akademika Lebedeva str., St. Petersburg, 194044</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7972-1286</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карев</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Karev</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197022, г. Санкт-Петербург, ул. Профессора Попова, д. 9</p></bio><bio xml:lang="en"><p>9, Professor Popov str., St. Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1343-4663</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титович</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Titovich</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, г. Санкт-Петербург, ул. Профессора Попова, д. 14, лит. А</p></bio><bio xml:lang="en"><p>14A, Prof. Popova str., Saint-Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3325-187X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ерёмин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>199004, г. Санкт-Петербург, В. О. Большой пр., д. 31</p></bio><bio xml:lang="en"><p>31, Bolshoy pr., Saint-Petersburg, 199004</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России)<country>Россия</country></aff><aff xml:lang="en">St. Petersburg State Chemical and Pharmaceutical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Институт высокомолекулярных соединений РАН (ИВС РАН)<country>Россия</country></aff><aff xml:lang="en">Institute of macromolecular compounds<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">ФГБВОУ ВО «Военно-медицинская академии имени С. М. Кирова» Министерства обороны Российской Федерации<country>Россия</country></aff><aff xml:lang="en">S. M. Kirov Military Medical Academy<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">ФГБУ «Детский научно-клинический центр инфекционных болезней» ФМБА<country>Россия</country></aff><aff xml:lang="en">Children's Scientific and Clinical Center of Infectious Diseases<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>01</day><month>09</month><year>2022</year></pub-date><volume>11</volume><issue>3</issue><fpage>209</fpage><lpage>219</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Семивеличенко Е.Д., Ермолаева А.А., Пономаренко В.В., Новоселов А.В., Плиско Г.А., Ивкин Д.Ю., Антонов В.Г., Карев В.Е., Титович И.А., Ерёмин А.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Семивеличенко Е.Д., Ермолаева А.А., Пономаренко В.В., Новоселов А.В., Плиско Г.А., Ивкин Д.Ю., Антонов В.Г., Карев В.Е., Титович И.А., Ерёмин А.В.</copyright-holder><copyright-holder xml:lang="en">Semivelichenko E.D., Ermolaeva A.A., Ponomarenko V.V., Novoselov A.V., Plisko G.A., Ivkin D.Y., Antonov V.G., Karev V.E., Titovich I.A., Eremin A.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/1303">https://www.pharmjournal.ru/jour/article/view/1303</self-uri><abstract><sec><title>Введение</title><p>Введение. В современной фармакологии все более широко используются молекулярные комплексы (МК), основанные на донорно-акцепторных или, на более слабых, межмолекулярных взаимодействиях, для стабилизации лекарственных форм в составе фармацевтических субстанций или их целевой доставки. Этот тренд активно развивается, т. к. молекулы образующие МК, имеющий определенный состав и пространственное строение, сохраняются и могут быть освобождены в неизменном виде. Использование МК в паре с «классическими» металлсодержащими координационными соединениями, усиливающими или модифицирующими действие активного компонента, позволяет разрабатывать новые, более эффективные лекарственные препараты с оптимизированными биодоступностью и активностью.</p></sec><sec><title>Цель</title><p>Цель. Оценка ранозаживляющего действия новых субстанций на основе водных систем, содержащих координационные соединения меди(II) или цинка с МК аденозин-сополимер N-винилпирролидона, в сравнении с препаратом Депантол®, на модели термического ожога у мышей.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Синтезированы моноядерные алаинатные комплексы Cu(Ala)2 · H2O и Zn(Ala)2 (Ala – алаинат-анион), сополимер N-винилпирролидона с кротоновой кислотой (ПВП-КК). Состав полученных соединений подтвержден данными элементного анализза на CHN(S)-анализаторе LECO CHNS(O)-932 (Elemental Microanalysis Ltd, Великобритания). ИК-спектры образцов регистрировались на приборах IRAffinity-1 (Shimadzu, Япония) (методом таблетирования образца с KBr) и IRTracer-100 (Shimadzu, Япония), оснащенном приставкой НПВО Specac Quest (Shimadzu Corporation, Япония). Потенциометрическое титрование функциональных групп сополимера ВП производили с помощью pH-метра PP-20 (Sartorius AG, Германия). Растворы препаратов готовились растворением ПВП-КК в полиэтиленгликоле (ПЭГ-400) с последующим внесением в препарат водной дисперсии аденозина (Ad) и соответствующего комплекса меди(II) или цинка. После моделирования термического ожога III степени оценивалась общая смертность в группах и динамика заживления травмированной области. В ходе эксперимента проводились гистологические исследования участков поврежденной ткани после окрашивания препаратов гематоксилином и эозином и проводилась обобщенная балльная оценка характеристик ожогового процесса, включающая оценку ширины и глубины образующейся рубцовой ткани, выраженности воспалительной инфильтрации и наличие гемосидероза в тканях.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Образование МК сополимера N-винилпирролидона с кротоновой кислотой с аденозином позволило приготовить растворы препаратов, содержащие до 5 % (масс.) последнего. В полученных образцах мольное соотношение ПВП-КК : Ad : M(Ala)2 составляло 100 : 10 : 1 (M = CuII, Zn), уровень рН полученных препаратов был равен 7.0–7.1. Полученные средства наносили на поврежденный участок кожи в объеме по 0,1 мл/сутки, каждой особи, ежедневно в течение 4 недель. Вводные субстанции на основе МК ПВП-КК : Ad : M(Ala)2 показали умеренное ранозаживляющее действие в сравнение с препаратом Депантол®, основанным на водно-жировой эмульсии. Субстанции, не содержащие металлокомплекса и содержащие Cu(Ala)2, показали лучшую эффективность в динамике заживления ожоговой травмы в сравнении с другими исследуемыми субстанциями, что сочеталось с низкой смертностью экспериментальных животных в данных группах (3 случая и 2 случая из 9 особей, соответственно). Препарат сравнения – Депантол®, в свою очередь, показал самый лучший результат, вероятно обусловленный содержанием в его составе, помимо декспантенола, характеризующегося ранозаживляющим действием, антисептика хлоргексидина, и жировой основы, уменьшающей дегидратацию травмированной области.</p></sec><sec><title>Заключение</title><p>Заключение. Экспериментальные субстанции, основанные на водных растворах МК аденозина-полимер, показали умеренный ранозаживляющий эффект, сопоставимый с референтным лекарственным средством, что, однако представляет достаточный интерес для дальнейшего изучения подобных композиций, или их модифицированных вариантов с добавлением противомикробных компонентов на моделях термического ожога, с целью создания новых, более эффективных лекарственных препаратов для заживления раневых поверхностей.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. In modern pharmacology, more and more widely used molecular complexes (MC) based on donor-acceptor or, on weaker, intermolecular interactions, to stabilize dosage forms in the composition of pharmaceutical substances or their targeted delivery. This trend is actively developing, because the molecules forming MK, which has a certain composition and spatial structure, are preserved and can be released unchanged. The use of MC in tandem with "classical" metal-containing coordination compounds, which enhance or modify the action of the active component, allows the development of new, more effective drugs with optimized bioavailability and activity.</p></sec><sec><title>Aim</title><p>Aim. Evaluation of the wound-healing effect of new substances based on aqueous systems containing coordination compounds of copper(II) or zinc with MC adenosine-copolymer of N-vinylpyrrolidone, in comparison with the drug Depantol® on a model of thermal burn in mice.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Mononuclear alainate complexes Cu(Ala)2 · H2O and Zn(Ala)2 (Ala – alainate-anion), copolymer of N-vinylpyrrolidone with crotonic acid (PVP-CA) have been synthesized. The composition of the obtained compounds was confirmed by the data of elemental analysis on a CHN (S) analyzer LECO CHNS (O) 932 (Elemental Microanalysis Ltd, Great Britain). IR spectra of the samples were recorded on a IRAffinity-1 (Shimadzu, Japan) instrument (by tabletting a sample with KBr) and a IRTracer-100 (Shimadzu, Japan) instrument equipped with a Specac Quest ATR attachment (Shimadzu Corporation, Japan). Potentiometric titration of the functional groups of the VP copolymer was performed using a PP-20 pH meter (Sartorius AG, Germany). The solutions of the preparations were prepared by dissolving PVP-KK in polyethylene glycol (PEG-400), followed by the addition of an aqueous dispersion of adenosine (Ad) and the corresponding complex of copper(II) or zinc into the preparation. After modeling a thermal burn of the third degree, the overall mortality in the groups and the dynamics of healing of the injured area were assessed. During the experiment, histological studies of areas of damaged tissue after staining of preparations with hematoxylin and eosin were carried out and a generalized scoring assessment of the characteristics of the burn process was carried out, including an assessment of the width and depth of the formed scar tissue, the severity of inflammatory infiltration and the presence of hemosiderosis in the tissues.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The formation of the MC of the copolymer of N-vinylpyrrolidone with crotonic acid with adenosine made it possible to prepare solutions of preparations containing up to 5 % (wght.) Of the latter. In the obtained samples, the molar ratio of PVP-CA : Ad : M(Ala)2 was 100 : 10 : 1 (M = CuII, Zn), the pH level of the obtained preparations was 7.0–7.1. The resulting funds were applied to the damaged area of the skin in a volume of 0.1 ml/day, each individual, daily for 4 weeks. Introductory substances based on MC PVP-CA : Ad : M(Ala)2 showed a moderate wound healing effect in comparison with the drug Depantol®, based on a water-fat emulsion. Substances that do not contain a metal complex and contain Cu(Ala)2 showed better efficiency in the dynamics of healing a burn injury in comparison with other studied substances, which was combined with a low mortality rate of experimental animals in these groups (3 cases and 2 cases out of 9 individuals, respectively). The reference drug – Depantol®, in turn, showed the best result, probably due to the content in its composition, in addition to dexpanthenol, which is characterized by a wound-healing effect, chlorhexidine antiseptic, and a fatty base, which reduces the dehydration of the injured area.</p></sec><sec><title>Conclusion</title><p>Conclusion. Experimental substances based on aqueous solutions of adenosine-polymer MK showed a moderate wound healing effect comparable to the reference drug, which, however, is of sufficient interest for further study of such compositions, or their modified versions with the addition of antimicrobial components on thermal burn models, in order to creation of new, more effective drugs for the healing of wound surfaces.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ожог</kwd><kwd>травма</kwd><kwd>молекулярные комплексы</kwd><kwd>полимеры</kwd><kwd>аденозин</kwd><kwd>координационные соединения</kwd><kwd>гистология</kwd></kwd-group><kwd-group xml:lang="en"><kwd>burns</kwd><kwd>trauma</kwd><kwd>molecular complexes</kwd><kwd>polymers</kwd><kwd>adenosine</kwd><kwd>coordination compounds</kwd><kwd>histology</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Роуз Л. Х. Раны. Диагностика и лечение. Атлас-справочник. М.: ГЕОТАР-Медиа; 2021. 536 с.</mixed-citation><mixed-citation xml:lang="en">Rose L. H. Wounds. Diagnosis and treatment. Atlas-reference book. Moscow: GEPTAR-Media; 2021. 538 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Jeschke M. G., van Baar M. E., Choudhry M. A., Chung K. K., Gibran N. S., Logsetty S. Burn injury. Nature Reviews Disease Primers. 2020;6(1). Doi: 10.1038/s41572-020-0145-5.</mixed-citation><mixed-citation xml:lang="en">Jeschke M. G., van Baar M. E., Choudhry M. A., Chung K. K., Gibran N. S., Logsetty S. Burn injury. Nature Reviews Disease Primers. 2020;6(1). Doi: 10.1038/s41572-020-0145-5.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Janos C.-D., Gallagher J. J., Norbury W. B., Finnerty C. C, Herndon D. N., Culnan D. M. Treatment of Infection in Burn Patients. Total Burn Care. 2018;4:93–113. DOI: 10.1016/B978-0-323-47661-4.00011-3.</mixed-citation><mixed-citation xml:lang="en">Janos C.-D., Gallagher J. J., Norbury W. B., Finnerty C. C, Herndon D. N., Culnan D. M. Treatment of Infection in Burn Patients. Total Burn Care. 2018;4:93–113. DOI: 10.1016/B978-0-323-47661-4.00011-3.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Панарин Е. Ф., Лавров Н. А., Соловский М. В., Шальнова Л. И. Полимеры – носители биологически активных веществ. СПб: ЦОП «Профессия»; 2014. 304 с.</mixed-citation><mixed-citation xml:lang="en">Panarin E. F., Lavrov N. A., Solovskii M. V., Shalnova L. I. Polymers are carriers of biologically active substances. St. Petersburg: COP "Professiya". 2014. 304 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Панарин Е. Ф. Полимерные лекарства и биологически активные вещества. Полимеры и медицина. 2005;1:20–24.</mixed-citation><mixed-citation xml:lang="en">Panarin E. F. Polymer drugs and biologically active substances. Polymers and medicine. 2005;1:20–24. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Афиногенов Г. Е, Панарин Е. Ф. Антимикробные полимеры. СПб.: Гиппократ; 1993. 264 с.</mixed-citation><mixed-citation xml:lang="en">Afinogenov G. E., Panarin E. F. Antimicrobial polymers. St. Petersburg: Gippokrat. 1993. 264 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cui D., Gāo A., Liang H., Tian J., Li X., Shen Q. Nano coronavirus recombinant vaccine taking graphene oxide as carrier. Chinese patent CN202011031367.1A. 27.09.2020. Available at: https://patents.google.com/patent/CN112220919A/en. Accessed: 20.04.2022.</mixed-citation><mixed-citation xml:lang="en">Cui D., Gāo A., Liang H., Tian J., Li X., Shen Q. Nano coronavirus recombinant vaccine taking graphene oxide as carrier. Chinese patent CN202011031367.1A. 27.09.2020. Available at: https://patents.google.com/patent/CN112220919A/en. Accessed: 20.04.2022.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Veronese F. M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials. 2001;22(5):405–417. DOI: 10.1016/S0142-9612(00)00193-9.</mixed-citation><mixed-citation xml:lang="en">Veronese F. M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials. 2001;22(5):405–417. DOI: 10.1016/S0142-9612(00)00193-9.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Porfiryeva N. N. , Moustafine R. I. , Khutoryanskiy V. V. PEGylated Systems in Pharmaceutics. Polymer Science, Series C. 2020;62(1):62–74. DOI: 10.1134/S181123822001004X.</mixed-citation><mixed-citation xml:lang="en">Porfiryeva N. N. , Moustafine R. I. , Khutoryanskiy V. V. PEGylated Systems in Pharmaceutics. Polymer Science, Series C. 2020;62(1):62–74. DOI: 10.1134/S181123822001004X.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson D. L., Cox M. M. Principles of Biochemistry (4th ed.). New York: W. H. Freeman and Company. 2000. 1120 p. DOI: 10.1007/978-3-662-08289-8.</mixed-citation><mixed-citation xml:lang="en">Nelson D. L., Cox M. M. Principles of Biochemistry (4th ed.). New York: W. H. Freeman and Company. 2000. 1120 p. DOI: 10.1007/978-3-662-08289-8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Невская К. В. Роль модифицированных аденозином моноцитов в репаративной регенерации кожи при ожоговой травме. Дис. ... канд. мед. наук. Томск. 2015. Доступно по: http://medical-diss.com/medicina/rol-modifitsirovannyh-adenozinom-monotsitov-v-reparativnoy-regeneratsii-kozhi-pri-ozhogovoy-travme. Ссылка активна на 20.04.2022.</mixed-citation><mixed-citation xml:lang="en">Nevskaya K. V. The role of adenosine-modified monocytes in reparative skin regeneration in burn injury. [dissertation.] Tomsk. 2015. Available at: http://medical-diss.com/medicina/rol-modifitsirovannyh-adenozinom-monotsitov-v-reparativnoy-regeneratsii-kozhi-pri-ozhogovoy-travme. Accessed: 20.04.2022. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Звягинцева Т. В., Халин И. В. Метаболитотропная терапия хронических ран. СПб: ФОП Вировець А. П.; 2011. 183 с.</mixed-citation><mixed-citation xml:lang="en">Zvyagintseva T. V., Khalin I. V. Metabolitotropic therapy of chronic wounds. St. Petersburg: FOP Virovec' A. P.; 2011. 183 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Haskó G. Adenosine: an endogenous regulator of innate immunity. Trends in Immunology. 2004;25(1):33–39. DOI: 10.1016/j.it.2003.11.003.</mixed-citation><mixed-citation xml:lang="en">Haskó G. Adenosine: an endogenous regulator of innate immunity. Trends in Immunology. 2004;25(1):33–39. DOI: 10.1016/j.it.2003.11.003.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kapinos L. E., Operschall B. P., Larsen E., Sigel H. Understanding the Acid-Base Properties of Adenosine: The Intrinsic Basicities of N1, N3 and N7. Chemistry – A European Journal. 2011;17(29):8156–8164. DOI: 10.1002/chem.201003544.</mixed-citation><mixed-citation xml:lang="en">Kapinos L. E., Operschall B. P., Larsen E., Sigel H. Understanding the Acid-Base Properties of Adenosine: The Intrinsic Basicities of N1, N3 and N7. Chemistry – A European Journal. 2011;17(29):8156–8164. DOI: 10.1002/chem.201003544.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lippert B. Cisplatin: chemistry and biochemistry of a leading anticancer drug. Weinheim: Wiley-VCH. 2006. 576 p.</mixed-citation><mixed-citation xml:lang="en">Lippert B. Cisplatin: chemistry and biochemistry of a leading anticancer drug. Weinheim: Wiley-VCH. 2006. 576 p.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Marlin R., Balasubramaniyan S., Govindharaju R., Meenakshi V. M., Jayalakshmi B., Ramachandramoorthy T. Synthesis, spectral characterization and biopotential significance of Сo (II) and Ni (II) complexes with biologically active ligands. International Journal of Pharmaceutical Sciences and Drug Research. 2020;12(1):22–28. DOI: 10.25004/IJPSDR.2020.120104.</mixed-citation><mixed-citation xml:lang="en">Marlin R., Balasubramaniyan S., Govindharaju R., Meenakshi V. M., Jayalakshmi B., Ramachandramoorthy T. Synthesis, spectral characterization and biopotential significance of Сo (II) and Ni (II) complexes with biologically active ligands. International Journal of Pharmaceutical Sciences and Drug Research. 2020;12(1):22–28. DOI: 10.25004/IJPSDR.2020.120104.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Rajalakshmi S., Vimalraj S., Saravanan S., Preeth D. R., Shairam M., Anuradha D. Synthesis and characterization of silibinin/phenanthroline/neocuproine copper(II) complexes for augmenting bone tissue regeneration: an in vitro analysis. JBIC Journal of Biological Inorganic Chemistry. 2018;23(5):753–762. DOI: 10.1007/s00775-018-1566-4.</mixed-citation><mixed-citation xml:lang="en">Rajalakshmi S., Vimalraj S., Saravanan S., Preeth D. R., Shairam M., Anuradha D. Synthesis and characterization of silibinin/phenanthroline/neocuproine copper(II) complexes for augmenting bone tissue regeneration: an in vitro analysis. JBIC Journal of Biological Inorganic Chemistry. 2018;23(5):753–762. DOI: 10.1007/s00775-018-1566-4.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gumireddy K., Li A., Cao L., Yan J., Liu L., Xu X., Pazoles C., Huang Q. NOV-002, A Glutathione Disulfide Mimetic, Suppresses Tumor Cell Invasion and Metastasis. Journal of Carcinogenesis &amp; Mutagenesis. 2013;S7:1–6. DOI: 10.4172/2157-2518.s7-002.</mixed-citation><mixed-citation xml:lang="en">Gumireddy K., Li A., Cao L., Yan J., Liu L., Xu X., Pazoles C., Huang Q. NOV-002, A Glutathione Disulfide Mimetic, Suppresses Tumor Cell Invasion and Metastasis. Journal of Carcinogenesis &amp; Mutagenesis. 2013;S7:1–6. DOI: 10.4172/2157-2518.s7-002.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Jenderny S., Lin H., Garrett T., Tew K. D., Townsend D. M. Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicity. Biomedicine &amp; Pharmacotherapy. 2010;64(1):73–76. DOI: 10.1016/j.biopha.2009.09.009.</mixed-citation><mixed-citation xml:lang="en">Jenderny S., Lin H., Garrett T., Tew K. D., Townsend D. M. Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicity. Biomedicine &amp; Pharmacotherapy. 2010;64(1):73–76. DOI: 10.1016/j.biopha.2009.09.009.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Warra A. A. Transition metal complexes and their application in drugs and cosmetics – A Review. J. Chem. Pharm. Res. 2011;3(4):951–958.</mixed-citation><mixed-citation xml:lang="en">Warra A. A. Transition metal complexes and their application in drugs and cosmetics – A Review. J. Chem. Pharm. Res. 2011;3(4):951–958.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mazurowska L., Mojski M. Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. Journal of Cosmetic Science. 2008;59(1):59–69.</mixed-citation><mixed-citation xml:lang="en">Mazurowska L., Mojski M. Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. Journal of Cosmetic Science. 2008;59(1):59–69.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Abendrot M., Kalinowska-Lis U. Zinc-containing compounds for personal care applications. International Journal of Cosmetic Science. 2018;40:319–327. DOI: 10.1111/ics.12463.</mixed-citation><mixed-citation xml:lang="en">Abendrot M., Kalinowska-Lis U. Zinc-containing compounds for personal care applications. International Journal of Cosmetic Science. 2018;40:319–327. DOI: 10.1111/ics.12463.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Толмачевой Е. А., ред. Видаль-2021. Справочник Видаль. Лекарственные препараты в России. 2021. М.: Видаль Рус. 2021. 1120 с.</mixed-citation><mixed-citation xml:lang="en">Tolmacheva E. A., ed. Vidal-2021. The Vidal Handbook. Medicines in Russia. 2021. Moscow: Vidal Rus. 2021. 1120 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Терехов Р. П., Селиванова И. А., Анурова М. Н., Жевлакова А. К., Никитин И. Д., Цонг Ж., Ма С., Янг Ф., Донг Ж., Ляо Й. Сравнительное изучение ранозаживляющих свойств псевдополиморфных модификаций дигидрокверцетина. Бюллетень экспериментальной биологии и медицины. 2020;10:452–456. DOI: 10.47056/0365-9615-2020-170-10-452-456.</mixed-citation><mixed-citation xml:lang="en">Terekhov R. P., Selivanova I. A., Anurova M. N., Zhevlakova A. K., Nikitin I. D., Tsong J., Ma S., Young F., Dong J., Liao Y. Comparative study of the wound healing properties of pseudopolymorphic modifications of dihydroquercetin. Bulletin of Experimental Biology and Medicine. 2020;10:452–456 (In Russ.) DOI: 10.47056/0365-9615-2020-170-10-452-456.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Machicao F., Muresanu D. F., Hundsberger H. Pleiotropic neuroprotective and metabolic effects of Actovegin’s mode of action. Journal of the Neurological Sciencesruen. 2012;322(1–2):222–227. DOI: 10.1016/j.jns.2012.07.069.</mixed-citation><mixed-citation xml:lang="en">Machicao F., Muresanu D. F., Hundsberger H. Pleiotropic neuroprotective and metabolic effects of Actovegin’s mode of action. Journal of the Neurological Sciencesruen. 2012;322(1–2):222–227. DOI: 10.1016/j.jns.2012.07.069.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Koskovac M., Cupara S., Kipic M., Barjaktarevic A., Milovanovic O., Kojicic K., Markovic M. Sea Buckthorn Oil—A Valuable Source for Cosmeceuticals. Cosmetics. 2017;4(4):40. DOI: 10.3390/cosmetics4040040.</mixed-citation><mixed-citation xml:lang="en">Koskovac M., Cupara S., Kipic M., Barjaktarevic A., Milovanovic O., Kojicic K., Markovic M. Sea Buckthorn Oil—A Valuable Source for Cosmeceuticals. Cosmetics. 2017;4(4):40. DOI: 10.3390/cosmetics4040040.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Уваров Д. А. Анализ структуры государственных закупок лекарственных средств с недоказанной эффективностью. Электронный вестник. 2020;80:86–107. DOI: 10.24411/2070-1381-2020-10065.</mixed-citation><mixed-citation xml:lang="en">Uvarov D. A. State Procurement Structure of Medicines with Unproved Efficiency. Electronic Bulletin. 2020;80:86–107. (In Russ.) DOI: 10.24411/2070-1381-2020-10065.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Calvo R., Sartoris R. P., Calvo H. L., Chagas E. F., Rapp R. E. Antiferromagnetic spin chain behavior and a transition to 3D magnetic order in Cu(D,L-alanine) 2 : Roles of H-bonds. Solid State Sciences. 2016;55:144–151. DOI: 10.1016/j.solidstatesciences.2016.03.005.</mixed-citation><mixed-citation xml:lang="en">Calvo R., Sartoris R. P., Calvo H. L., Chagas E. F., Rapp R. E. Antiferromagnetic spin chain behavior and a transition to 3D magnetic order in Cu(D,L-alanine) 2 : Roles of H-bonds. Solid State Sciences. 2016;55:144–151. DOI: 10.1016/j.solidstatesciences.2016.03.005.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Priya A. P., Srinivasan V., Subhashini R., Vijayalakshmi A. Synthesis and physicochemical properties of a promising nonlinear optical metal organic crystal: Bis(L-alaninato)zinc(II). Materials Letters. 2020;266:127474. DOI: 10.1016/j.matlet.2020.127474.</mixed-citation><mixed-citation xml:lang="en">Priya A. P., Srinivasan V., Subhashini R., Vijayalakshmi A. Synthesis and physicochemical properties of a promising nonlinear optical metal organic crystal: Bis(L-alaninato)zinc(II). Materials Letters. 2020;266:127474. DOI: 10.1016/j.matlet.2020.127474.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Борисенко М. С. Водорастворимые реакционноспособные сополимеры N-винилпирролидона и сополимеры акриловой кислоты с 2-оксиэтилметакрилатом как носители противотуберкулёзных препаратов. Дисс. ... канд. хим. наук. Санкт-Петербург; 2019. Доступно по: https://www.dissercat.com/content/vodorastvorimye-reaktsionnosposobnye-sopolimery-n-vinilpirrolidona-i-sopolimery-akrilovoi. Ссылка активна на 20.04.2022.</mixed-citation><mixed-citation xml:lang="en">Borisenko M. S. Water-soluble reactive copolymers of N-vinylpyr-rolidone and copolymers of acrylic acid with 2-hydroxyethyl methacrylate as carriers of anti-tuberculosis drugs. [dissertation.] Saint Petersburg; 2019. Available at: https://www.dissercat.com/content/vodorastvorimye-reaktsionnosposobnye-sopolimery-n-vinilpirrolidona-i-sopolimery-akrilovoi. Accessed: 20.04.2022. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Abdullahi A., Amini-Nik S., Jeschke, M. G. Cellular and Molecular Life Sciences. Animal models in burn research. 2014;71(17):3241–3255.</mixed-citation><mixed-citation xml:lang="en">Abdullahi A., Amini-Nik S., Jeschke, M. G. Cellular and Molecular Life Sciences. Animal models in burn research. 2014;71(17):3241–3255.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kordestani S. S. Atlas of wound Healing. Amsterdam: Elsevier Inc.; 2019. 180 p. DOI: 10.1016/C2018-0-03292-2.</mixed-citation><mixed-citation xml:lang="en">Kordestani S. S. Atlas of wound Healing. Amsterdam: Elsevier Inc.; 2019. 180 p. DOI: 10.1016/C2018-0-03292-2.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Brownson E. G., Gibran N. S., Heimbach D. M. Evaluation of the burn wound: management decisions. In: Total Burn Care. Amsterdam: Elsevier Inc.; 2018. 87-92 p.</mixed-citation><mixed-citation xml:lang="en">Brownson E. G., Gibran N. S., Heimbach D. M. Evaluation of the burn wound: management decisions. In: Total Burn Care. Amsterdam: Elsevier Inc.; 2018. 87-92 p.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
